Form 8-K - Current report:
SEC Accession No. 0001493152-18-003311
Filing Date
2018-03-14
Accepted
2018-03-14 08:46:18
Documents
3
Period of Report
2018-03-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 29899
2 ex99-1.htm EX-99.1 14206
3 ex99-1_001.jpg GRAPHIC 18359
  Complete submission text file 0001493152-18-003311.txt   70701
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 613-9882-6723
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 300662986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54878 | Film No.: 18688390
SIC: 2834 Pharmaceutical Preparations